Dendritic Cell Vaccine

Sarcosine promotes trafficking of dendritic cells and improves efficacy of anti-tumor dendritic cell vaccines via CXC chemokine family signaling
Farhad Dastmalchi, Aida Karachi, Changlin Yang, Hassan Azari, Elias Joseph Sayour, Anjelika Dechkovskaia, Alexander Loren Vlasak, Megan Ellen Saia, Rolando Eladio Lovaton, Duane Anthony Mitchell, Maryam Rahman

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 321; DOI: 10.1186/s40425-019-0809-4
Using whole immune system characterization (immune profiling) to identify immune biomarkers to determine patient selection, dosing, and efficacy of new immune therapies
Michael Gustafson, Yi Lin, Dennis Gastineau, Ian Parney, Allan Dietz

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P90; DOI: 10.1186/2051-1426-3-S2-P90
Superiority of dendritic cell vaccine vs tumor cell vaccine: survival by stratification subsets in MACVAC randomized Phase II trial of patient-specific vaccines utilizing antigens from autologous melanoma tumor cell lines
Robert O Dillman, Edward McClay, Thomas Amatruda, George Semeniuk, Clark Haskins, Robert Weber, David Burtzo, Carol DePriest, Denysha Carbonell, Andrew Cornforth

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P202; DOI: 10.1186/2051-1426-3-S2-P202
CD8+ T cell responses in metastatic melanoma patients receiving an adenovirally antigen engineered dendritic cell vaccine +/- IFN-α
Samuel Du, Patricia M Santos, Hussein Tawbi, Ahmad Tarhini, John M Kirkwood, Lisa H Butterfield

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P149; DOI: 10.1186/2051-1426-3-S2-P149
Selective costimulation by IL-15R/IL-15, but not IL-2R/IL-2, allows the induction of high numbers of tumor-specific CD8+ T cells by human dendritic cells matured in conditions of acute inflammation
Morten Hansen, Eva Wieckowski, Inge Marie Svane, Robert P Edwards, Pawel Kalinski

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P223; DOI: 10.1186/2051-1426-3-S2-P223
Dendritic cell vaccine treatment for indolent B cell non-hodgkin lymphoma: clinical trial in progress
Yi Lin, Thomas Atwell, Adam Weisbrod, Mary Maas, Adam Armstrong, Michael Deeds, Peggy Bulur, Michael Gustafson, Zhe Zhang, Louis Porrata, Svetomir Markovic, Patrick Johnston, Ivana Micallef, David Inwards, Joseph Colgan, Stephen Ansell, Dennis Gastineau, Allan Dietz, Thomas Witzig

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P76; DOI: 10.1186/2051-1426-2-S3-P76
High-dose IL-2 in metastatic melanoma: better survival in patients who also received patient-specific autologous tumor cell vaccine
Robert O Dillman, Carol DePriest, Stephanie E McClure

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P208; DOI: 10.1186/2051-1426-1-S1-P208
In vitro and in vivo priming of T cells using dendritic cells loaded with internal cell localization signals fused cancer testis antigens
Slavoljub Milosevic

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P24; DOI: 10.1186/2051-1426-1-S1-P24
Allogeneic dendritic cell (DC) vaccination as an “off the shelf” treatment to prevent or delay relapse in elderly acute myeloid leukemia patients: results of Phase I/IIa safety and feasibility study
Tanja de Gruijl, Saskia Santegoeds, Sandra van Wetering, Satwinder Kaur Singh, Anthony Hall, Arjan A van de Loosdrecht, Ada Kruisbeek

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P205; DOI: 10.1186/2051-1426-1-S1-P205

Log in using your username and password

Main menu

Log in using your username and password

You are here

Dendritic Cell Vaccine